Fentanyl Transdermal Patch and Foslevodopa: Interaction Details
- Fentanyl Transdermal Patch
- DuragesicAbstralSubsys +3 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fentanyl Transdermal Patch and Foslevodopa interaction:
Foslevodopa
We don't have a separate drug information page for Foslevodopa. The FDA's drug directory lists it as part of Vyalev (foscarbidopa and foslevodopa). Have a question about Foslevodopa? Ask a pharmacist, free →
Fentanyl Transdermal Patch
- Duragesic
- Abstral
- Subsys
- Ionsys
- Actiq
- Fentora
What Happens When You Take Fentanyl Transdermal Patch With Foslevodopa
What can happen when they are taken together (rated Major)
An increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
When foscarbidopa/foslevodopa is given together with depressants, the risk of CNS depression may be higher, so caution is warranted if the drugs are used concurrently.1
The Fentanyl Transdermal Patch and Foslevodopa Interaction, Explained
Foslevodopa is a form of levodopa that treats Parkinson's disease, and it can cause sleepiness or dizziness in some people. The fentanyl patch (Duragesic) is a strong pain reliever that also causes drowsiness and slows breathing. Taken together, these effects may add up, so you could feel more sleepy, foggy, or slowed down than with either one alone.
This concern is based on how the drugs work rather than on large studies, but because fentanyl is a strong opioid, it is worth taking seriously. Please don't change anything on your own. Tell your pharmacist or doctor about both medicines, and ask them how to watch for extra drowsiness. Your care team can manage this with careful dosing and monitoring.
Mechanism: (). Foscarbidopa/foslevodopa (levodopa/carbidopa infusion) can cause somnolence, sudden sleep onset, and dizziness. Transdermal fentanyl is a mu-opioid with sedative and respiratory depressant effects. Neither drug alters the other's , so the interaction is not . Magnitude is not quantified.
- Evidence: Theoretical; labeling advises caution with depressants. Onset unspecified.
- Severity: Major, given the 's risk.
- Management: Use caution. Individualize doses, and monitor for , respiratory depression, and or dizziness, especially during fentanyl initiation or dose changes. Counsel on driving and other hazardous activities, and on avoiding additional CNS depressants such as alcohol.
See the 3 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fentanyl Transdermal Patch and Foslevodopa Interact
The likely mechanism
How to Manage the Fentanyl Transdermal Patch and Foslevodopa Interaction
Your care team can usually manage this by tailoring your doses and checking in on how you feel. The documented advice is to use caution when these are taken together.
- Keep taking both medicines as prescribed unless your prescriber tells you otherwise.
- Tell your pharmacist and prescriber about all sedating products, including alcohol, sleep aids, and anxiety medicines.
- Report unusual sleepiness, confusion, dizziness, or slowed breathing right away. Seek emergency help for trouble breathing or being very hard to wake.
- Use caution with driving or hazardous tasks until you know how you respond.
Your team may monitor you more closely, especially when doses change.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fentanyl Transdermal Patch or Foslevodopa need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
2 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: Eunerpan, Melperonhydrochlorid
Melperone may counteract the anti-parkinsonian effects of levodopa.2
-
Report 2 · Study title
Prescribing information: Nipolept, zotepine
Using zotepine together with levodopa may reduce the effectiveness of levodopa, owing to the dopamine-antagonizing properties of zotepine.3
Fentanyl Transdermal Patch and Foslevodopa: Common Questions
How serious is the Fentanyl Transdermal Patch and Foslevodopa interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fentanyl Transdermal Patch and Foslevodopa interaction managed?
Your care team can usually manage this by tailoring your doses and checking in on how you feel. The documented advice is to use caution when these are taken together. Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Tell your pharmacist and prescriber about all sedating products, including alcohol, sleep aids, and anxiety medicines. Report unusual sleepiness, co… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Fentanyl Transdermal Patch and Foslevodopa Interaction
Ask in your own words about taking Fentanyl Transdermal Patch and Foslevodopa together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (3)
- Product Information: VYALEV(TM) subcutaneous injection, foscarbidopa and foslevodopa subcutaneous injection. AbbVie Inc (per FDA), North Chicago, IL, 2024. DailyMed
- Product Information: Eunerpan(R), Melperonhydrochlorid. Nordmark Arzneimittel GmbH, Uetersen, 1991.
- Product Information: Nipolept(R), zotepine. Klinge Pharma GmbH, Munich, Germany, 1994.
Other Serious Interactions of Fentanyl Transdermal Patch and Foslevodopa
Also serious with Foslevodopa
- IsocarboxazidContraindicated
- Methylene BlueContraindicated
- PhenelzineContraindicated
- TranylcypromineContraindicated
Also serious with Fentanyl Transdermal Patch
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.